Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Bruns Ingmar
Chief Medical Officer at Zentalis Pharmaceuticals. Filing since 6 Feb 2025.
CIK 0001838041
Company
Date
Role
Action
Shares
Amount
Of holding
ZNTL
Zentalis Pharmaceuticals, Inc.
9 Feb 2026
Chief Medical Officer
Sold at will
335
$801.62
1.0%
ZNTL
Zentalis Pharmaceuticals, Inc.
6 Feb 2026
Chief Medical Officer
Sold at will
2,962
$7.20K
8.1%
ZNTL
Zentalis Pharmaceuticals, Inc.
6 Feb 2025
Chief Medical Officer
Bought
20,000
$45.66K
120%
3 decisions on file.
